The anti-snoring devices market is estimated to be valued at USD 1.6 Bn in 2024 and is expected to reach USD 2.58 Bn by 2031, growing at a compound annual growth rate (CAGR) of 7.1% from 2024 to 2031. Consistent with the growing prevalence of sleep disorders and increasing awareness about treatment options, demand for anti-snoring devices is expected to increase steadily over the forecast period.

The market is driven by the rising number of people suffering from sleep apnea and snoring issues. Advancements in technologies used in anti-snoring devices are further fueling the demand. Mandibular advancement devices are gaining popularity due to their effectiveness and relatively lower cost compared to other anti-snoring devices like tongue stabilizing devices and nasal devices.

Market Driver - Increasing prevalence of sleep disorders such as sleep apnea

The increasing prevalence of various sleep disorders like sleep apnea across the globe has been a major driver for the anti-snoring devices market. Sleep apnea refers to a potentially serious sleep disorder that disrupts one's normal breathing pattern during sleep. There are various types of sleep apnea but the most common one is obstructive sleep apnea wherein the muscles relax around the throat whilst sleeping and block the airway, causing breathing to stop briefly. The person usually starts breathing again with an abrupt snort or choking sound as the upper airway muscles relax again. Sleep apnea causes oxygen levels in the blood to drop which disturbs the person's sleep as the symptoms can persist throughout the entire night.

According to various estimates, sleep apnea currently affects over 1 billion people worldwide with prevalence rates estimated to be as high as 38% among men and 16% among women. The rates are even higher among the elderly population. The main causes can range from obesity and excess weight gain to aging and genetics. Both obstructive sleep apnea and central sleep apnea disrupt a natural night of sleep and prevent the person from falling into the deep, dreaming stages of sleep needed to feel refreshed in the morning. Long term effects can contribute to serious health issues such as high blood pressure, heart disease, diabetes, and stroke if left untreated.

The standard treatment option for moderate to severe sleep apnea involves CPAP therapy which provides continuous positive airway pressure through a mask during sleep to keep the airways open. However, CPAP adherence has always been a challenge due to issues like discomfort, dry mouth, and claustrophobia making alternative treatment options attractive. This is where anti-snoring devices have gained popularity as an effective method to alleviate snoring caused by sleep apnea which disrupts partner's sleep too. Mouthpieces and nasal devices help improve breathing by opening the airways during sleep and reducing episodes of cessation in breathing. Thus, the increasing disease burden of sleep apnea globally has spurred demand for anti-snoring devices as a treatment and preventive measure.

Market Driver - Rising awareness about the importance of sleep health through campaigns

Rising awareness among general public regarding the importance of maintaining healthy sleep hygiene and the risks associated with inadequate sleep has been another key factor driving greater adoption of anti-snoring devices. Various social media campaigns, online blogs and articles in print media have highlighted issues like the detrimental effects of disrupted sleep on health, productivity and wellbeing. With busier lifestyles and stressful work routines making good quality sleep elusive, people are realizing they need to take proactive measures to address sleep issues before they become chronic.

Campaigns by non-profit organizations as well as governments have focused on educating especially young white collar professionals, new parents and the elderly population on basic sleep tips, troubleshooting noise disruptions like snoring early, and understanding the link between poor sleep and diseases like diabetes, obesity etc. The message that healthy sleep should be priority, not compromised has been an important takeaway. Simultaneously, technological advancements have enabled the democratization of access to simple tools for common sleep conditions. Socially acceptable anti-snoring devices represent a preferable treatment solution compared to prescription sleep aids leaving an encouraging impression.

Manufacturers of anti-snoring products have also complemented awareness initiatives through effective digital marketing campaigns highlighting positive reviews and testimonials. The discreet, easy-to-use image has boosted acceptance of these devices for personal use and even gifting purposes.

Market Challenge - Complications and side effects associated with the use of anti-snoring devices

One of the major challenges faced by the anti-snoring devices market is the complications and side effects associated with the use of these devices. Anti-snoring devices work by changing the structure of the airways or jaw positioning which can sometimes lead to discomfort, pain or other issues for users. For example, mouthpieces that adjust the jaw positioning can cause teeth alignment problems or temporomandibular joint (TMJ) discomfort over prolonged usage. Nasal devices use straps or clips around the nose which may lead to irritation, congestion or nose bleeds in sensitive users. Some devices also alter the natural breathing pattern which can cause shortness of breath, dry mouth or headaches in certain individuals. The invasive nature of certain anti-snoring devices and the changes they induce in the delicate structures of the nose, mouth or throat make complications an inherent risk that limits widespread adoption. Device manufacturers need to focus on improving designs and making products more comfortable to use over long periods of time so as to reduce the risk of side effects for a larger consumer base. Addressing complications effectively is a challenge holding back further growth of the industry.

Market Opportunity - Technological advancements leading to the development of more effective devices

One key opportunity area for the anti-snoring devices market is the technological advancements leading to the development of more effective devices. Constant innovation is introducing new product categories and better product designs that are more effective in treating snoring issues. For example, the introduction of respiratory polygraphy has allowed tracking of sleep patterns more precisely, helping develop oral appliances that better target obstructive sleep apnea. Advancements in materials allow for lightweight, durable devices made of comfortable silicone or memory foam instead of bulkier plastic options of the past. Electronic sensors and tracking offer potential for monitoring adherence and automating adjustments. Rapid prototyping enables easy, low-cost trials of new prototypes. The increasing digitization of healthcare also opens new opportunities for connectivity with sleep monitoring apps and remote diagnosis. Overall, continued innovation expanding the treatment scope and improving user experience of anti-snoring devices presents a strong opportunity for industry players to explore and drive future growth.

Product innovation has been a core strategy for market leaders to drive growth. For example, in 2018 ResMed launched its AirMini travel CPAP machine, 50% smaller than previous versions for improved portability. This addressed needs of frequent travelers and helped ResMed gain a 4% rise in revenues.

Another effective strategy is broadening product portfolios. In 2016, PureSleep launched 4 new anti-snoring mouthpieces to target different price points and types of snoring. They saw a 30% increase in sales that year. Similarly, in 2019 Apnea Sciences diversified into nasal dilators when their mouthpieces sales plateaued, driving a 15% jump in revenues.

Partnering with healthcare providers is a winning strategy. In 2015, SomnoMed partnered with over 500 dental professionals to certify and fit their oral appliance therapy. This improved access to treatment and specialists' recommendations drove a 25% rise in monthly prescriptions filled. Similarly, in 2017 Phillips Respironics partnered with 250 sleep clinics and saw a 20% increase in sales.

Targeting developing markets with cheaper products has paid off for some. For example, in 2013, GSK launched inexpensive nasal strips in India and China priced 30% lower. This helped them gain a foothold in fast-growing Asian markets and contributed to a 10% rise in annual profits.

Insights, By Device Type: Mandibular advancement devices sub-segment contributes the highest share of the market owing to its effectiveness and comfortable design

Mandibular advancement devices hold the largest share of 35.3% in the anti-snoring devices market due to their proven effectiveness and comfortable design. These devices work by pulling the lower jaw gently forward during sleep, which keeps the airway open. This action improves breathing patterns and reduces or eliminates snoring.

Many clinical studies have demonstrated that mandibular advancement devices can provide significant relief from snoring and mild to moderate sleep apnea. A recent meta-analysis found they reduced the apnea-hypopnea index by over 50% in patients with mild sleep apnea. The consistency of positive results across studies has led many doctors to recommend them as a first-line treatment option over other device types.

In addition, mandibular advancement devices are generally preferred by patients due to their comfortable design. They can be molded precisely to fit the wearer's teeth, avoiding issues like leaks, pain, or sore spots that are more common with less customizable devices. This comfort factor contributes to high levels of adherence to therapy. Most patients report they do not notice they are wearing the device once asleep.

The customized, non-invasive nature of mandibular advancement devices also means they can be prescribed without a lengthy, expensive sleep study. This accessibility makes them the easiest anti-snoring solution for many people to try first before considering more complex or costly alternatives like CPAP machines. Overall, mandibular advancement devices lead the market because they deliver clear clinical benefits in a simple, comfortable form.

Insights, By Distribution Channel: Hospital and retail pharmacies sub-segment contributes the highest share of the market owing to accessibility and expertise provided

The largest share of 45.8% in the anti-snoring devices market is held by the hospital and retail pharmacies distribution channel. This is due to the accessibility and expertise that these outlets provide. Patients find it convenient to purchase anti-snoring solutions through their local hospital or retail pharmacy. These locations are ubiquitous and familiar points of access within most communities. People can simply add the device to their regular shopping or visit during standard pharmacy hours. This walk-in availability makes hospital/retail pharmacies the easiest initial option to explore anti-snoring treatment.

Furthermore, these distribution points employ healthcare professionals like pharmacists, respiratory therapists or sleep specialists who can provide expert advice. Patients benefit from the ability to consult directly with clinical experts when selecting the right anti-snoring device option. Pharmacists in particular receive extensive training to evaluate each individual's situation, recommend suitable products, fit devices properly, and advise on effective long-term usage.

The on-site clinic expertise from medical professionals differentiates hospital/retail pharmacies from other channels lacking this guidance resource. It empowers customers to make informed purchase decisions with confidence. As a result, these convenient and knowledgeable distribution points lead the market in serving the majority of anti-snoring device customers.

The anti-snoring devices market is set to grow significantly due to the rising prevalence of sleep disorders and related health conditions such as COPD, obesity, and depression. The market is driven by increased awareness of sleep health and the development of advanced devices. The North American region is expected to dominate the market due to the high prevalence of sleep-related issues and the presence of key players.

The major players operating in the anti-snoring devices market include ResMed, Koninklijke Philips NV, SomnoMed, Fisher & Paykel Healthcare Limited, GSK plc., Apnea Sciences, Meditas, Evantis Inc., Rotech Healthcare, The Pure Sleep Company, Innovative Health Technologies, Tomed GmbH, Whole You Inc., AccuMED Corporation and Vyaire Medical.

• In July 2024, Snorles launched GenioFlex, a novel device that manages snoring without the need for nighttime use, thus not disrupting sleep quality.
• In May 2022, Illusion Aligners introduced a new Anti-Snoring Device (ASD), offering ease of use and comfort for uninterrupted sleep.
• In February 2021, FDA approved the eXciteOSA mouthpiece, a device used while awake to reduce snoring by improving tongue muscle function.

• By Device Type
  • Mandibular Advancement Devices
  • Tongue Stabilizing Devices
  • Continuous Positive Airway Pressure (CPAP) Devices
  • Others
• By Distribution Channel
  • Hospital and Retail Pharmacies
  • Online Pharmacies
  • Others